This prevents lipohypertrophy, a condition where repeated injections in the same spot cause fatty tissue to thicken and harden, which then alters absorption unpredictably
Lilly has not yet submitted for FDA approval, and industry estimates suggest a potential launch in 2028
FDA Finalizes Guidance on Patient-Focused Drug Development (PFDD) The new PFDD guidance reinforces that clinical trials must capture what matters most to patients symptom burden, quality of life, daily functioning, and treatment tolerability
Without baseline data, it is impossible to determine whether a peptide is actually helping or whether natural disease fluctuation is responsible for any changes you observe
Skeletal muscle healing in sites distant from the injection location shows improvement in BPC-157-treated animal models, suggesting systemic circulation of the peptide rather than purely localized activity
Avoid prolonged exposure to heat, moisture and direct light
